Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godavari Drugs Ltd has informed the BSE that the trading window for its designated persons and their immediate relatives will remain closed from Wednesday, April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and financial year ending March 31, 2026. This closure is in line with SEBI's Insider Trading Regulations, 2015 and the company's internal Code of Conduct. The company also mentioned that the date of the board meeting to approve the audited results will be communicated separately. The intimation was signed by Venkatesh Achanta, Company Secretary and Compliance Officer.
This is a routine compliance filing and not a business event. The trading window closure is standard practice before results are announced and signals that the company's Q4 and FY26 audited numbers are expected soon. No direct impact on shareholders or stock price is expected from this announcement.